Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02923037
Other study ID # VICC BRE 16104
Secondary ID NCI-2016-01402
Status Terminated
Phase N/A
First received
Last updated
Start date September 1, 2016
Est. completion date March 2019

Study information

Verified date March 2019
Source Vanderbilt-Ingram Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot clinical trial studies Hatha yoga in reducing physical and emotional problems in breast cancer survivors with stage II-III lymphedema. Yoga practices may benefit breast cancer survivors with lymphedema as they directly support lymph transport (postures, breathing, relaxation) and emotional well-being (relaxation, meditation).


Description:

PRIMARY OBJECTIVES:

I. To determine the feasibility of a modified yoga program for breast cancer survivors (BCS) with lymphedema.

II. To identify and document required modifications for a safe and feasible practice.

III. To obtain recruitment estimates and determine barriers to recruitment (acceptability).

IV. To evaluate implementation fidelity (adherence and competence) and barriers to implementation fidelity.

V. To establish safety. VI. To assess satisfaction. VII. To determine the preliminary efficacy of a modified yoga program for lymphedema in BCS, and associated physical and psychological symptoms/symptom burden, and overall health status.

OUTLINE:

Patients undergo an initial yoga evaluation for 60 minutes. Patients then undergo their first guided yoga practice session for 30-60 minutes and subsequent guided yoga sessions for 30-90 minutes.

3 times a week for 4 weeks, and twice a week for an additional 4 weeks. Patients are also encouraged to complete home yoga practice for 30 to 90 minutes every day for 8 weeks.


Recruitment information / eligibility

Status Terminated
Enrollment 27
Est. completion date March 2019
Est. primary completion date November 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Lymphedema Group:

- Lymphedema, symptomatic of stage II or III based upon screening responses; or L-Dex reading of = 7 at initial visit,

- > 3 months (mths) post-breast cancer treatment

- No active cancer

- Has compression sleeve

- Ability to understand English in order to complete questionnaires

- Willing to do guided and home yoga practice

- Willing and able to provide informed consent as demonstrated by passing screening tool questions that includes the Short Portable Mental Status Questionnaire

- Medical clearance

- Reliable transportation to the study site

No Lymphedema Group:

- No known lymphedema or intermittent swelling, not symptomatic of Stage II or III lymphedema (L-Dex = 7)

- >3 months post- breast cancer treatment

- No active cancer

- Ability to understand English in order to complete questionnaires

- Willing to do guided and home Yoga practice

- Willing and able to provide informed consent as demonstrated by passing screening tool questions that includes the Short Portable Mental Status Questionnaire

- Medical clearance

- Reliable transportation to the study site.

Exclusion Criteria (Both Groups):

- Active cancer

- Undergoing radiation therapy or chemotherapy

- Medical conditions that would prohibit the safe implementation of a yoga practice (e.g., vertigo, compromised mental status)

- Active yoga practice < 3 months

- Currently undergoing phase I complete decongestive therapy (CDT)

- Inability to complete study forms

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Yoga
Complete guided and home yoga sessions
Other:
tape measurement of arm
Ancillary studies
Quality-of-Life Assessment
Ancillary studies
ldex measurement of arms


Locations

Country Name City State
United States Vanderbilt University School of Nursing Nashville Tennessee

Sponsors (2)

Lead Sponsor Collaborator
Vanderbilt-Ingram Cancer Center National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pose Modifications number of poses requiring modifications as indicated in the modification form Up to 8 weeks
Primary Assess safety Number of participants with treatment-related adverse events as assessed by the CTCAE v4.0 Up to 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT05507346 - A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema N/A
Completed NCT06067880 - Surgical Intervention and Lymphatic Diseases.
Active, not recruiting NCT04797390 - A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema N/A
Completed NCT02676752 - Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors With Lymphedema and Fibrosis
Completed NCT06323200 - Lymphedema Duration on Lymphatic Vessel Quality and Outcomes After LVA
Completed NCT02506530 - Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema N/A
Completed NCT02253186 - Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphoedema N/A
Terminated NCT02020837 - A Pilot Study Assessing the Effect of Lymphaticovenous Micro-Anastomosis in the Treatment of Postmastectomy Lymphedema Early Phase 1
Recruiting NCT01318785 - Therapeutical Assessment of Compression Armsleeves for Lymphatic Indications Phase 2
Enrolling by invitation NCT02375165 - Biomarkers for the Detection of Lymphatic Insufficiency
Completed NCT02308488 - Study of Prone Accelerated Breast And Nodal IMRT N/A
Completed NCT01112189 - Use of Stem Cells in Lymphedema Post Mastectomy Phase 1/Phase 2
Completed NCT00852930 - Low Level Laser Treatment and Breast Cancer Related Lymphedema Phase 4
Completed NCT00743314 - Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer Early Phase 1
Recruiting NCT06237907 - Pyroptosis and Ferroptosis in the Pathophysiology of Lymphedema
Terminated NCT01580800 - National Breast Cancer and Lymphedema Registry
Suspended NCT05366699 - LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy N/A
Completed NCT06249360 - Lymphatic System Reflux After Lymphatic Operation
Completed NCT06220903 - The Effect of Complex Decongestive Therapy in Patients With Lymphedema N/A
Recruiting NCT06041958 - Effects of Extracorporeal Shock Wave Therapy and Pulse Electromagnetic Field Therapy on Lymphoedema N/A